QUANTIFY RESEARCH is a global partner to the pharmaceutical industry in close partnership with academia, patients, public institutions & clinical experts.
Real-world evidence & analytics
Quantify is the leading provider of RWE generated from the world-renouned Nordic data. Through our local presence, expert staff, institutional know-how and more than 10 years’ hands-on experience with the Nordic data, we offer an unparalleled ability to advise and execute Nordic RWE studies with local and global applications. Quantify has a successful track record of advising clients on securing Nordic ethical approval, data access, and optimizing analysis for commercial or regulatory purposes. We also offer RWE services in the EU, UK, and US.
Modelling, Access & Strategy
Quantify is a global provider of health economic evidence and a specialist provider of Nordic market access services including economic models, reimbursement dossiers, and strategic advice. Our experience and expertise ensures an optimized, streamlined market access process across the Nordics. For non-technical stakeholders, Quantify also develops value tools and visualisation dashboards to enhance communication. Our expert staff include ex-payers, ex-pharma, modelling experts, and experienced project managers.
Evidence review & synthesis
Quantify has long standing experience reviewing, interpreting and communicating evidence as part of targeted or systematic literature reviews (SLR). Our team ensures these activities are done systematically, with a focus on usability, to support knowledge management and commercialization activities. QUANTIFY is experienced in summarizing the results of this work through meta-analyses and narrative reviews. Our team consists of 50% PhDs and integrated AI solutions to provide our clients with the very best services.
Press
Decision tree for Evidence Reviews
Evidence reviews support both the Health technology assessments and healthcare decision making internal to the organisations. If you are a pharmaceutical / Biotech / Med-tech company, you may plan to utilise various types of reviews to make informed decisions on asset prioritisation and budget allocations, and to inform the value stories in development. We at Quantify will love to guide your decision on what type of review you should […]
Quantify to attend its first US ISPOR this year in Boston, during May 7-10
?? ???? ???? ??-???????? ??? ??? ??????? ??? ???????? ??? ???? ?? ???????? ????-????? ????
We’re getting the word out early – Quantify is excited to attend its first US ISPOR this year in Boston, during May 7-10! We would love to connect and discuss how Nordic and other European RWD can be used to support your regulatory and commercial needs. Here is a teaser for what you can expect […]
Quantify to attend World Evidence, Pricing and Access Congress
We are thrilled to announce that our team will be in attendance at the upcoming World Evidence, Pricing and Access Congress, which will take place in Amsterdam this March. As a highly regarded event in our field, we are eager to connect with like-minded professionals and share our diverse experiences and expertise.
We are eager to meet you! If you are interested in scheduling a meeting in advance, […]
Konstantin Macheridis joins Quantify!
We have some great news to share with you all! Quantify grew stronger last week with the arrival of Konstantin Macheridis as the newest Senior Project Leader in our Stockholm team. Most recently, Kostas served as a Project Leader/Health Economist at the National Board of Health and Welfare, and before that as a Health economist at the Swedish Dental and Pharmaceutical Benefits Agency. Kostas brings with him a […]